TwitterLinkedInYouTubeslideshareflickrIFPMA - Global Health Matters - BlogRSS

International Federation of Pharmaceutical Manufacturers & Associations

Bringing Psoriasis into the Light

09 May 2014,

10:00 - 12:00 Friday 9 May 2014

The Restaurant ‘Le Vieux Bois’ - Avenue de la Paix 12, 1202 Geneva

Psoriasis affects 125 million individuals across the globe. It has been known as a distinct disease for more than 200 years. It causes widespread suffering and puts an enormous psychosocial burden on those affected. It also contributes to many co-morbidities such as psoriasis arthritis, depression, heart attacks and strokes. Psoriasis-associated economic costs to individuals and societies run into billions of dollars.

Later this month, the World Health Assembly will discuss a resolution on psoriasis, which is a major milestone for psoriasis campaigners.

To help inform the discussions, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) invite you to a Geneva Pharma Forum on psoriasis where a panel of experts will address critical issues such as awareness of psoriasis, research and access to care.


UPDATED! Developing World Health Partnerships Directory

The research-based pharmaceutical industry engages in a wide range of public-private partnerships...

IFPMA Code of Practice

Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...

Interview Series

The IFPMA Interview Series is a video library of interviews with people from different walks of...